Harpoon Therapeutics is a preclinical stage biotechnology company founded by MPM that is developing a novel class of T cell recruiting antibodies against validated hematologic and solid tumor targets.
Some data provided by Crunchbase
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Harpoon Therapeutics or any companies featured above.
This profile is based on publicly available information and is intended to be informative in nature.
To learn more about whether you're eligible, typical investment size, company valuation, and share price, request access here.